CA2852177A1 - Co-agonistes du recepteur glucagon/glp-1 - Google Patents

Co-agonistes du recepteur glucagon/glp-1 Download PDF

Info

Publication number
CA2852177A1
CA2852177A1 CA2852177A CA2852177A CA2852177A1 CA 2852177 A1 CA2852177 A1 CA 2852177A1 CA 2852177 A CA2852177 A CA 2852177A CA 2852177 A CA2852177 A CA 2852177A CA 2852177 A1 CA2852177 A1 CA 2852177A1
Authority
CA
Canada
Prior art keywords
glucagon
seq
peptide
amino acid
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2852177A
Other languages
English (en)
Inventor
Jonathan Day
David L. Smiley
Richard D. Dimarchi
Elisabetta Bianchi
Antonello Pessi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Indiana University Research and Technology Corp
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Indiana University Research and Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA, Indiana University Research and Technology Corp filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority claimed from CA2728284A external-priority patent/CA2728284C/fr
Publication of CA2852177A1 publication Critical patent/CA2852177A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA2852177A 2008-06-17 2009-06-16 Co-agonistes du recepteur glucagon/glp-1 Abandoned CA2852177A1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US7226908P 2008-06-17 2008-06-17
US61/073,269 2008-06-17
US7816808P 2008-07-03 2008-07-03
US61/078,168 2008-07-03
US9041208P 2008-08-20 2008-08-20
US61/090,412 2008-08-20
US17747609P 2009-05-12 2009-05-12
US61/177,476 2009-05-12
CA2728284A CA2728284C (fr) 2008-06-17 2009-06-16 Co-agonistes du recepteur glucagon/glp-1

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2728284A Division CA2728284C (fr) 2008-06-17 2009-06-16 Co-agonistes du recepteur glucagon/glp-1

Publications (1)

Publication Number Publication Date
CA2852177A1 true CA2852177A1 (fr) 2009-12-23

Family

ID=50935114

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2852177A Abandoned CA2852177A1 (fr) 2008-06-17 2009-06-16 Co-agonistes du recepteur glucagon/glp-1

Country Status (1)

Country Link
CA (1) CA2852177A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2528618A4 (fr) * 2010-01-27 2015-05-27 Univ Indiana Res & Tech Corp Conjugués d'antagoniste du glucagon et d'agoniste du gip et compositions pour le traitement de troubles métaboliques et de l'obésité
WO2016209707A1 (fr) * 2015-06-22 2016-12-29 Eli Lilly And Company Composés de co-agonistes du glucagon et du glp-1
CN112898405A (zh) * 2021-01-22 2021-06-04 深圳市图微安创科技开发有限公司 多肽化合物及其在预防或治疗糖尿病或糖尿病并发症中的应用
CN113081955A (zh) * 2020-01-09 2021-07-09 鲁南制药集团股份有限公司 一种免疫抑制剂单克隆抗体的制剂

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2528618A4 (fr) * 2010-01-27 2015-05-27 Univ Indiana Res & Tech Corp Conjugués d'antagoniste du glucagon et d'agoniste du gip et compositions pour le traitement de troubles métaboliques et de l'obésité
IL294099B1 (en) * 2015-06-22 2023-11-01 Lilly Co Eli Glucagon and GLP-1 co-agonist compounds
WO2016209707A1 (fr) * 2015-06-22 2016-12-29 Eli Lilly And Company Composés de co-agonistes du glucagon et du glp-1
US9938335B2 (en) 2015-06-22 2018-04-10 Eli Lilly And Company Glucagon and GLP-1 co-agonist compounds
JP2018521043A (ja) * 2015-06-22 2018-08-02 イーライ リリー アンド カンパニー グルカゴン及びｇｌｐ−１共アゴニスト化合物
AU2016283984B2 (en) * 2015-06-22 2018-11-29 Eli Lilly And Company Glucagon and GLP-1 co-agonist compounds
JP2020007338A (ja) * 2015-06-22 2020-01-16 イーライ リリー アンド カンパニー グルカゴン及びｇｌｐ−１共アゴニスト化合物
EP3785724A1 (fr) * 2015-06-22 2021-03-03 Eli Lilly and Company Composés de co-agonistes du glucagon et du glp-1
IL294099B2 (en) * 2015-06-22 2024-03-01 Lilly Co Eli Glucagon and GLP-1 co-agonist compounds
EA038720B1 (ru) * 2015-06-22 2021-10-11 Эли Лилли Энд Компани Коагонист рецептора glp-1 и рецептора глюкагона для лечения диабета типа 2, ожирения, безалкогольной жировой болезни печени и безалкогольного стеатогепатита
JP2022031787A (ja) * 2015-06-22 2022-02-22 イーライ リリー アンド カンパニー グルカゴン及びｇｌｐ－１共アゴニスト化合物
IL285231B (en) * 2015-06-22 2022-08-01 Lilly Co Eli Co-agonistic compounds for glucagon and glp-1
CN113081955A (zh) * 2020-01-09 2021-07-09 鲁南制药集团股份有限公司 一种免疫抑制剂单克隆抗体的制剂
CN113081955B (zh) * 2020-01-09 2023-10-24 鲁南制药集团股份有限公司 一种免疫抑制剂单克隆抗体的制剂
CN112898405B (zh) * 2021-01-22 2023-02-28 深圳市图微安创科技开发有限公司 多肽化合物及其在预防或治疗糖尿病或糖尿病并发症中的应用
CN112898405A (zh) * 2021-01-22 2021-06-04 深圳市图微安创科技开发有限公司 多肽化合物及其在预防或治疗糖尿病或糖尿病并发症中的应用

Similar Documents

Publication Publication Date Title
CA2728284C (fr) Co-agonistes du recepteur glucagon/glp-1
US9790263B2 (en) GIP receptor-active glucagon compounds
EP2300035B1 (fr) Agonistes mixtes basés sur gip destinés au traitement de troubles métaboliques et de l obésité
RU2560254C2 (ru) АНАЛОГИ ГЛЮКАГОНА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ РАСТВОРИМОСТЬЮ И СТАБИЛЬНОСТЬЮ В БУФЕРАХ С ФИЗИОЛОГИЧЕСКИМИ ЗНАЧЕНИЯМИ Ph
WO2011163473A1 (fr) Analogues du glucagon présentant une solubilité et une stabilité améliorées dans des tampons à ph physiologique
CA2852177A1 (fr) Co-agonistes du recepteur glucagon/glp-1
AU2013200675A1 (en) Glucagon/GLP-1 receptor co-agonists
AU2013205144B2 (en) GIP-based mixed agonists for treatment of metabolic disorders and obesity

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20141112

FZDE Dead

Effective date: 20170313